ABL Diagnostics specializes in the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases (AIDS, viral hepatitis and tuberculosis) by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. Export accounts for 69.7% of net sales.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
26-08-14	€2.440	-3.17%	1,592
26-08-13	€2.520	+2.44%	2,269
26-08-12	€2.460	-1.60%	8,218
26-08-11	€2.500	+3.31%	2,920
26-08-10	€2.420	-2.42%	4,672

Real-time Euronext Paris

More quotes

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar

Real-time Euronext Paris 10:04:07 2026-08-14 EDT			5-day change	1st Jan Change
2.440 ^EUR	-3.17%		-1.61%	-18.67%

08-10	ABL Diagnostics Plans Listing Transfer to Euronext Growth Paris	MT
07-23	French Court OKs ABL Diagnostics' Industrial Plan to Acquire Texcell	MT

Market Cap	40.49M 46.72M 37.96M 34.61M 65.13M 4.46B 66.17M 447M 174M 2.23B 175M 172M 7.45B	P/E 2024	123x	P/E 2025	50x
Enterprise Value	41.43M 47.79M 38.84M 35.41M 66.63M 4.56B 67.69M 457M 179M 2.28B 179M 176M 7.62B	EV / Sales 2024	7,098,474x	EV / Sales 2025	6,185,843x
Free-Float	6.2%	Yield 2024	2.03%	Yield 2025	3.67%

08-10	ABL Diagnostics Plans Listing Transfer to Euronext Growth Paris	MT
07-23	French Court OKs ABL Diagnostics' Industrial Plan to Acquire Texcell	MT
07-22	ABL Diagnostics Société anonyme agreed to acquire Assets and Business Operations from Texcell SA for ?0.78 million.	CI
07-02	Abl Diagnostics Société Anonyme Approves Dividend Distribution for Fiscal Year 2025, Payable on July 7, 2026	CI
06-12	Abl Diagnostics Sa and Cdl Pharma Secure Multi-Year International Contract of Up to Eur 2.7 Million Through 2031	CI
06-12	ABL Diagnostics Signs Multi-year Contract to Provide Clinical Trial Services	MT
06-12	ABL Diagnostics Secures Multi-Year Contract with CDL Pharma
06-10	ABL Diagnostics Offers to Buy Texcell	MT
06-05	ABL divests block of ABL Diagnostics shares
06-01	ABL Diagnostics Société anonyme Provides Earnings Guidance for the Fiscal Year Ending December 31, 2026	CI
05-18	ABL Diagnostics Société anonyme Proposes Dividend for the Financial Year Ended December 31, 2025, Payable on July 7, 2026	CI
05-06	ABL Diagnostics Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2025	CI
11-14	Abl Diagnostics Appoints Eurobio Scientific as Exclusive Distributor for Its Vela Product Line in A Targeted Segment of the French Market	CI

08-07	ABL Diagnostics - Proposed Transfer of the Listing of Its Securities From the Regulated Market of Euronext Paris to Euronext Growth Paris	BU
07-29	ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL	BU
07-27	ABL Diagnostics Announces Amendment to the Equity Line and Share Loan Agreement Between Its Main Shareholder ABL SA (Luxembourg) and Alumni Capital	BU
07-23	ABL Diagnostics Selected by the Évry Commercial Court to Acquire TEXCELL’s Operations	BU
07-22	ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL	BU

ABL Diagnostics Stock

Stocks

ABLD

FR001400AHX6

Medical Equipment, Supplies & Distribution

Valuation: ABL Diagnostics

Chart: ABL Diagnostics

Latest news : ABL Diagnostics

Press Releases: ABL Diagnostics

News in other languages: ABL Diagnostics

Quotes and Performance

Course Extremes

Managers and Directors: ABL Diagnostics

Latest insider transactions

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Quotes

Income Statement and Estimates

Annual profits - Rate of surprise

08-10	Bourse : Innate signe avec SOBI, Apple se tourne vers CXMT
08-07	ABL Diagnostics vise un transfert sur Euronext Growth Paris
08-07	ABL Diagnostics - Projet de transfert de la cotation de ses titres du marché réglementé d'Euronext Paris vers Euronext Growth Paris
07-29	ABL Diagnostics : Cession d'un nouveau bloc d'actions par son actionnaire principal ABL
07-27	ABL Diagnostics annonce la signature d'un avenant au contrat d'Equity Line et de prêt de titres entre son actionnaire principal ABL SA (Luxembourg) et Alumni Capital

1 day	-3.17%
1 week	-1.61%
Current month	+0.83%
1 month	-2.40%
3 months	-27.81%
6 months	-32.22%
Current year	-18.67%

1 week	2.4	2.62
1 month	2.18	2.74
Current year	2.12	5
1 year	2.12	5
3 years	2.12	9.7
5 years	1.99	26
10 years	1.28	26

Director	Title	Age	Since
Noemie Sadoun CHM	Chairman	-	-
Laure Raffaelli BRD	Director/Board Member	-	-
Deborah Szafir BRD	Director/Board Member	-	-

Date	Insider	Type	Main position	Quantity	% Market Cap.
7/28/26	Advanced Biological Laboratories SA	Sell	Company	-60,000	0.3723%
7/20/26	Advanced Biological Laboratories SA	Sell	Company	-65,616	0.4072%
7/6/26	Advanced Biological Laboratories SA	Sell	Company	-62,308	0.3867%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ABL DIAGNOSTICS	-3.17%	-1.61%	-45.78%	-72.27%	46.72M
ABBOTT LABORATORIES	-0.19%	+3.03%	-14.08%	+4.69%	193B
MEDTRONIC PLC	+0.31%	+4.27%	-1.20%	+9.28%	116B
CENCORA, INC.	-0.48%	-4.05%	+4.28%	+63.88%	59.16B
HOYA CORPORATION	+0.32%	+3.92%	+38.42%	+65.14%	55.75B
BECTON, DICKINSON AND COMPANY	-0.14%	+2.91%	-6.66%	-35.61%	49.57B
DEXCOM, INC.	-0.65%	+7.60%	+14.04%	-21.22%	34.52B
MEDLINE INC.	+0.44%	+1.25%	-	-	31.22B
WEST PHARMACEUTICAL SERVICES, INC.	-0.07%	-2.02%	+40.91%	-13.24%	24.36B
TERUMO CORPORATION	+1.98%	+12.62%	-2.80%	+25.91%	24.25B
Average	-0.19%	+3.76%	+3.02%	+2.95%	58.74B
Weighted average by Cap.	-0.01%	+3.53%	+1.13%	+12.94%

	2024	2025
Net sales	5.87 6.77 5.5 5.02 9.44 646.26 9.59 64.79 25.29 323.5 25.42 24.87 1.08K	7.97 9.19 7.47 6.81 12.81 877.06 13.02 87.92 34.33 439.04 34.5 33.75 1.46K
Net income	285K 329K 267K 244K 459K 31.4M 466K 3.15M 1.23M 15.72M 1.24M 1.21M 52.43M	987K 1.14M 925K 843K 1.59M 109M 1.61M 10.89M 4.25M 54.38M 4.27M 4.18M 181M
Net Debt	2.02M 2.33M 1.9M 1.73M 3.25M 223M 3.31M 22.34M 8.72M 112M 8.77M 8.58M 372M	933K 1.08M 874K 797K 1.5M 103M 1.52M 10.29M 4.02M 51.4M 4.04M 3.95M 171M